Skip to main content
Log in

Immunopathology of ulcerative colitis and Crohn's disease, nonsurgical therapeutic considerations

  • Annotation
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ament ME (1975) Inflammatory disease of the colon: ulcerative colitis in Crohn's disease. J Pediat 86:322

    PubMed  Google Scholar 

  2. Asquith P (1979) Immunology of the gastrointestinal tract. Ch Livingstone, Edinburgh London

    Google Scholar 

  3. Baklien K, Brantzaeg P (1974) Local immunity and ulcerative colitis. Lancet II:411

    Google Scholar 

  4. Bendixen G (1969) Cellular hypersensitivity to components of intestinal mucosa in ulcerative colitis and Crohn's disease. Gut 10:631

    PubMed  Google Scholar 

  5. Binder V, Elsborg J, Greibel J, Hendriksen C, Hoy L, Jensen KB, Matzen JR, Marner B, Ries P, Willumsen L (1981) Disodium cromoglycate in the treatment of ulcerative colitis in Crohn's disease. Gut 22:55

    PubMed  Google Scholar 

  6. Blackstone NO, Riddell RH, Rogers BHG, Levin B (1981) Dysplasia associated mass detected by colonoscopy in long-standing ulcerative colitis: An indication for colectomy. Gastroenterol 80:366

    Google Scholar 

  7. Bläker F, Schäfer KH (1969) Neuere Erkenntnisse über Vorkommen, Ätiologie, Pathogenese und Therapie der Colitis ulcerosa im Kinderalter. Monatsschr Kinderheilk 117:52

    Google Scholar 

  8. Bläker F (1982) Was ist begründet, was ist gesichert in der pädiatrischen Therapie der Colitis ulcerosa und des Morbus Crohn. Monatsschr Kinderheilk 130:349

    Google Scholar 

  9. Brandtzaeg P, Baklien K (1976) Immunohistochemical studies of the formation and epithelial transport of immunoglobulins in normal and diseased human intestinal mucosa. Scand J Gastroenterol 11, 36:1

    Google Scholar 

  10. Campbell AC, Skinner JM, Hersey P, Roberts-Thomson P, Mac Lennan ICM, Truelove SC (1974) Immunosuppression in the treatment of inflammatory bowel disease. Changes in lymphoid subpopulations in the blood and rectal mucosa following cessation of treatment with azathioprine. Clin Exp Immunol 16:521

    Google Scholar 

  11. Carlsson HE, Lagercrantz R, Perlmann P (1977) Immunological studies in ulcerative colitis. Antibodies to colon antigen in patients with ulcerative colitis. Crohn's disease and other diseases. Scand J Gastroenterol 12:707

    PubMed  Google Scholar 

  12. Cooke WT (1981) Prognosis of Crohn's disease. Brit Med J 1791

  13. Editorial (1981) Treatment of ulcerative colitis. Brit Med J 1255

  14. Editorial (1981) Prognosis of Crohn's disease. Brit Med J 1416

  15. Editorial (1981) Short comments of the national Crohn's disease study: The exclusion of Azathioprine without adequate trial. Gastroenterol 80:193

  16. Elson CO, Graeff AS, James SP, Strober W (1981) Covert suppressor T-cells in Crohn's disease. Gastroenterol 80:1513

    Google Scholar 

  17. Engstrom JF, Arvanitakis C, Sagawa A, Abdou NI (1978) Secretory immunoglobuline deficiency in a family with inflammatory bowel disease. Gastroenterol 74:746

    Google Scholar 

  18. Gebbers JO, Otto HF (1982) Immunhistologische Befunde. In: Handbuch der inneren Medizin, Band III, Teil IV, Dickdarm. Springer, Berlin Heidelberg New York

    Google Scholar 

  19. Goldman P (1980) Metronidazol. New Engl J Med 303:1212

    PubMed  Google Scholar 

  20. Hafter F (1981) Differentialdiagnose der Colitis ulcerosa. Schweiz Med Wochenschr 111:773

    PubMed  Google Scholar 

  21. Hodgson HJF, Potter BJ, Jewell DP (1978) C 3 metabolism in ulcerative colitis and Crohn's disease. Clin Exp Immunol 28:490

    Google Scholar 

  22. Hodgson HJF, Potter BJ, Jewell DP (1977) Immune complexes in ulcerative colitis and Crohn's disease. Clin Exp Immunol 29:87

    Google Scholar 

  23. Hodgson HJF, Wands JR, Isselbacher KJ (1978) Decreased suppressor cell activity in inflammatory bowel disease. Clin Exp Immunol 32:451

    PubMed  Google Scholar 

  24. Jewell DP (1973) Etiology of ulcerative colitis. Proc Roy Soc Med 66:1031

    PubMed  Google Scholar 

  25. Kirschner B, Klich J, Kalman S, Defararo M, Rosenberg IH (1981) Reversal of growth retardation in Crohn's disease with therapy emphazising oral nutrition restitution. Gastroenterol 80:10

    Google Scholar 

  26. Kirsner JB, Shorter RG (1980) Inflammatory bowel disease. Lea and Febiger, Philadelphia

    Google Scholar 

  27. Klotz U, Meier K, Fischer C, Heinke K (1980) Therapeutic efficacy of Sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease. New Engl J Med 26:1499

    Google Scholar 

  28. Kraft SC, Kirsner JB (1971) Immunological apparatus of the gut and inflammatory bowel disease. Gastroenterol 60:922

    Google Scholar 

  29. Lagercrantz R, Perlmann P, Hammerstrom S (1971) Immunological studies in ulcerative colitis. Gastroenterol 60:381

    Google Scholar 

  30. Lennard-Jones K (1981) Azathioprine and 6-Mecaptopurin have a role in the treatment of Crohn's diseas. Dig Dis Sci 26:364

    Google Scholar 

  31. Mac Pherson BR, Albertine RJ, Beeken WL (1976) Immunological studies in patients with Crohn's disease. Gut 17:100

    PubMed  Google Scholar 

  32. Mayberry JF, Phodes EJ, Allan R, Newcombe RG, Regan GM, Cemberlain L, Wragg KE (1981) Diet in Crohn's disease. Dig Dis Sci 26:444

    PubMed  Google Scholar 

  33. Meyers S, Sachar DB, Taub RN, Janowitz HD (1976) Anergy to dinitrochlorobenzene and depression of T lymphocytes in Crohn's disease and ulcerative colitis. Gut 17:911

    PubMed  Google Scholar 

  34. Nielsen H, Binder V, Dougherty H, Svehag SE (1978) Circulating immune complexes in ulcerative colitis. Correlation to disease activity. Clin Exp Immunol 31:72

    PubMed  Google Scholar 

  35. O'Donoghue DP, Kumar P (1979) Rectal IgE cells in inflammatory bowel disease. Gut 20:149

    PubMed  Google Scholar 

  36. Otto HF (1981) Immunpathogenetische und ultrastrukturelle Aspekte der Colitis ulcerosa. Schweiz Med Wochenschr 11:768

    Google Scholar 

  37. Otto HF, Gebbers JO (1981) Electromicroscopic cytochemical and immune histological observations in Chron's disease of the ileum and colon. Virch Arch 291:189

    Google Scholar 

  38. Ries P, Willumsen L (1981) Disodium cromoglycate in the treatment of ulcerative colitis and Crohn's disease. Gut 22:55

    PubMed  Google Scholar 

  39. Sachar DB, Auslander MO, Walfish JS (1980) Etiological theories of inflammatory bowel disease. Clin Gastroenterol 9:231

    PubMed  Google Scholar 

  40. Schäfer KH, Bläker F (1971) Experiences with immunosuppressive therapy in childhood ulcerative colitis. Z Kinderheilk 110:317

    PubMed  Google Scholar 

  41. Schäfer KH, Bläker F (1976) Clinical and immunological aspects of pathogenesis and treatment of ulcerative colitis in children. Paediatrician 5:57

    Google Scholar 

  42. Shorter RG, Tomasi TB, Huizenga KA, Spencer RJ, Stobe JD (1976) The immunology of chronic ulcerative colitis and Crohn's disease. Ann NY Acad Sci 278:586

    PubMed  Google Scholar 

  43. Singleton JW (1981) Azathioprine has a very limited role in the treatment of Crohn's disease Dig Dis Sci 26:368

    PubMed  Google Scholar 

  44. Thayer WR (1976) Are the inflammatory bowel diseases immune complex diseases? Gastroenterol 70:136

    Google Scholar 

  45. Thiele HG, Schmiegel PH, Bläker F (19) Immunphänomene bei chronisch entzündlichen Darmerkrankungen. In: Handbuch der Inneren Medizin, Band 3, Teil IV. Springer, Berlin Heidelberg New York

  46. Watson DW (1969) Immune responses and the gut. Gastroenterol 56:944

    Google Scholar 

  47. Ward M (1977) The pathogenesis of Crohn's disease. Lancet II:903

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Curriculum vitae. Prof. Felix Bläker was born in 1935 in Borken, Westfalia, Germany. He graduated at the Medical Faculty of the University of Hamburg in 1960. His post graduate training included pathology (Hamburg), gynaecology and obstetrics (Essen), surgery and internal medicine (Bonn). Since 1964 he is a staff member in the pediatric clinic of the University Hamburg. 1968 Privatdozent, 1973 Professor of pediatrics, head of the division for pediatric nephrology. His main research interest is in immunopathology in kidney diseases, in immunoinflammatory disorders and in immunoinsufficiency. Studies in immunoreactive diseases of gastrointestinal tract were performed in a close collaboration with Prof. Schäfer.

Curriculum vitae. K. H. Schäfer was born 1911 in Köslin/Pommern, Germany at that time. Graduation and thesis 1935 at the faculty of Medicine in München, Germany. Since 1937 postgraduate training in Pediatrics and clinical training at the Children's Hospital of the University of Köln including experimental Pharmacology at the Institute of Pharmacology of the University of Köln, 1941 Habilitation, 1945–1951 first assistant doctor at the Children's Hospital of the University of Göttingen. 1948 Assoc. Professor, 1951 Chairman of Pediatrics at the University of Hamburg, since November 1979 retired. Member of the European Societies for Pediatric Research for Hematology and Immunology and for Gastroenterology and Nutrition.

Main topics of research have been infectious diseases, hematology, especially iron metabolism, and gastroenterology.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bläker, F., Schäfer, K.H. Immunopathology of ulcerative colitis and Crohn's disease, nonsurgical therapeutic considerations. Eur J Pediatr 139, 162–164 (1982). https://doi.org/10.1007/BF01377348

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01377348

Keywords

Navigation